Wade G W & Inc Danaher Corp Transaction History

Wade G W & Inc

$3.08 Billion
Q4 2023

A detailed history of Wade G W & Inc transactions in Danaher Corp stock. As of the latest transaction made, Wade G W & Inc holds 2,112 shares of DHR stock, worth $578,392. This represents 0.02% of its overall portfolio holdings.

Number of Shares

2,112

Previous 2,111 0.05%

Holding current value

$578,392

Previous $524,000 6.68%

% of portfolio

0.02%

Previous 0.02%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	BUY	$185.1 - $233.13 $185 - $233	1 Added 0.05%	2,112 $489,000
Q3 2023 Nov 08, 2023	BUY	$233.08 - $265.59 $209,305 - $238,499	898 Added 74.03%	2,111 $524,000
Q2 2023 Aug 10, 2023	BUY	$224.99 - $256.14 $7,199 - $8,196	32 Added 2.71%	1,213 $291,000
Q1 2023 May 09, 2023	SELL	$239.75 - $277.0 $58,738 - $67,865	-245 Reduced 17.18%	1,181 $298,000
Q4 2022 Feb 10, 2023	BUY	$241.42 - $282.29 $15,933 - $18,631	66 Added 4.85%	1,426 $378,000
Q3 2022 Nov 10, 2022	BUY	$247.06 - $1507.4 $22,976 - $140,188	93 Added 7.34%	1,360 $351,000
Q2 2022 Aug 09, 2022	SELL	$237.11 - $299.66 $38,174 - $48,245	-161 Reduced 11.27%	1,267 $321,000
Q4 2021 Feb 09, 2022	BUY	$292.08 - $329.01 $16,648 - $18,753	57 Added 4.16%	1,428 $470,000
Q3 2021 Nov 03, 2021	BUY	$272.21 - $332.43 $39,198 - $47,869	144 Added 11.74%	1,371 $418,000
Q2 2021 Aug 12, 2021	SELL	$225.08 - $271.69 $1,125 - $1,358	-5 Reduced 0.41%	1,227 $329,000
Q1 2021 May 05, 2021	SELL	$212.38 - $245.9 $13,592 - $15,737	-64 Reduced 4.94%	1,232 $277,000
Q4 2020 Feb 03, 2021	BUY	$212.5 - $245.46 $275,400 - $318,116	1,296 New	1,296 $288,000

Others Institutions Holding DHR

# of Institutions

2,391

Shares Held

563M

Call Options Held

3.94M

Put Options Held

4.1M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $199B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wade G W & Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wade G W & Inc with notifications on news.

Account